Chronic pyelonephritis and hypertensive vascular disease often coexist clinically, and a primary and causal role in the relationship usually has been attributed to the renal inflammatory disease. In experimental pyelonephritis, however, where the sequence of events and the presence of other complicating factors can be controlled, such a causal role has not been clearly established. A number of investigators have noted development of hypertension in rats with chronic pyelonephritis, but this has been either mild, of low and irregular incidence, or associated with unilateral nephrectomy, or hydronephrosis, or both (1-3). On the other hand, in our previous studies in rats, in which renal infection was produced by a nonobstructive technique that results in damage to the kidney only by the inflammatory process, chronic pyelonephritis, from any one of several different bacterial species, has not been followed by significant hypertension or vascular disease. Nor have the development of renal failure or the additional insults of infection with a mixed bacterial flora and reduction of renal mass by unilateral nephrectomy produced hypertension in this model (4, 5). Such animals, however, do show a greater response than normal rats to the hypertensive influences of salt and desoxycorticosterone (6). Similarly, Guze and Kalmanson have demonstrated the failure of hypertension to develop in rats with chronic nonobstructive pyelonephritis produced by repeated injections of Enterococci alone and with Escherichia coli (7).
(Submitted for publication July 23, 1962 ; accepted October 18, 1962) Chronic pyelonephritis and hypertensive vascular disease often coexist clinically, and a primary and causal role in the relationship usually has been attributed to the renal inflammatory disease. In experimental pyelonephritis, however, where the sequence of events and the presence of other complicating factors can be controlled, such a causal role has not been clearly established. A number of investigators have noted development of hypertension in rats with chronic pyelonephritis, but this has been either mild, of low and irregular incidence, or associated with unilateral nephrectomy, or hydronephrosis, or both (1) (2) (3) . On the other hand, in our previous studies in rats, in which renal infection was produced by a nonobstructive technique that results in damage to the kidney only by the inflammatory process, chronic pyelonephritis, from any one of several different bacterial species, has not been followed by significant hypertension or vascular disease. Nor have the development of renal failure or the additional insults of infection with a mixed bacterial flora and reduction of renal mass by unilateral nephrectomy produced hypertension in this model (4, 5) . Such animals, however, do show a greater response than normal rats to the hypertensive influences of salt and desoxycorticosterone (6) . Similarly, Guze and Kalmanson have demonstrated the failure of hypertension to develop in rats with chronic nonobstructive pyelonephritis produced by repeated injections of Enterococci alone and with Escherichia coli (7) .
Conversely, rats made chronically hypertensive by either renal artery constriction or administra-* Supported by grants from the Health Research and Services Foundation of Allegheny County, Pa., and the U. S. Public Health Service; presented in part at the meetings of the Southern Section of the American Federation for Clinical Research, January, 1962. tion of salt and desoxycorticosterone show a significant increase in susceptibility to pyeloneplhritis after hematogenous challenge with E. coli (6, 8, 9) . These studies suggest that pyelonephritis can be a complication rather than a cause of the vascular disease, resulting from increased vulnerability of the hypertensive kidney to infection.
Two different mechanisms have been proposed to explain the vulnerability of chronically hypertensive rats to renal infection: 1) renal damage or metabolic alterations occurring secondarily to hypertension, and 2) changes in renal hemodynamics accompanying hypertension (6) . The present investigation was designed to evaluate the effects of hemodynamic changes alone. From study of susceptibility to pyelonephritis during an acute episode of elevated blood pressure, organic changes in the kidney as a result of prolonged hypertension would be unlikely. Angiotensin II and norepinephrine were used for producing such an acute episode. Both are powerful pressor agents. Angiotensin is at least five to ten times more potent than norepinephrine (10) , and, in contrast to norepinephrine, has a stronger effect on the visceral blood vessels. Moreover, angiotensin affects primarily the arterial side of the capillary, and has a lesser ability than norepineplhrine to constrict veins (11, 12 (12) . With direct arterial cannulation, however, it has been established that significant increase in blood pressure occurs in rats with doses of norepinephrine as low as 5 /Ag per kg of body weight (14) . In voivo inspection of kidneys after intravenous inj ection of 10 /Ag of norepinephrine failed to demonstrate the alteration in gross appearance noted after 10 /.g of angiotensin.
With norepinephrine the same experimental design as with angiotensin was followed, but 1-and 4-hour sacrifice periods were omitted. Three groups of rats again were studied. Group I (28 rats) received 10 Ag of norepinephrine in 0.5 ml of E. coli broth.2 Group II (21 rats) received 0.5 ml of E. coli only, and Group III (4 rats) received 10 1Ag of norepinephrine in sterile tryptose broth. Liver and spleen cultures were performed on all rats sacrificed at 24 hours. Again, as a "quality control," the incidence of kidney lesions and bacterial counts were determined in groups of rats subjected to injection of E. ccli and renal massage. Growth ficial blood pressures on randomly selected rats also were within normal limits in all three groups.
2. Gross incidence of pyelonephritis. At sacrifice all kidneys were carefully examined for evidence of grossly detectable pyelonephritis according to criteria previously described (4, 16 The data also show that microscopic evidence of pyelonephritis was present in Group I when gross evidence was lacking at 1 and 2 weeks, in contrast to Group II, where gross and microscopic incidences of pyelonephritis were identical at all periods. Furthermore, as expected from the gross appearance of the lesions at 1 and 2 weeks, the histological data indicated that the rare lesions in Group II kidneys were small and showed minimal extension through the kidney parenchyma. whereas lesions in Group I presented the typical wedge-shaped appearance described in previous studies (13, 16 fold. Blood levels of E. coli were virtually identical in both groups at 24 hours and were negative by 1 week. Liver and spleen cultures performed at the 24-hour sacrifice period, terminal heart weights, and preinjection blood pressures again showed no differences between the groups (Table IV) .
2. Gross incidence of pyelonephritis. Rats who received E. coli and renal massage to serve as a check on the virulence of the organism showed a high incidence of pyelonephritis, as in previous studies (9, 12) . The data from these animals have been combined from both experiments in Table V . The rats sacrificed at 1 week accompanied the angiotensin study, and those at 24 hours and 10 days, the norepinephrine study. These data again confirm the ability of renal massage to localize infection in the kidney. They (6) . This explanation seems unlikely in the present study, since the duration of elevated blood pressure was much too brief to result in secondary damage, at least of sufficient degree to be detectable histologically.
Although the role of angiotensin in aldosterone production (17) (18) (19) , the effect of aldosterone on potassium excretion (18, 19) , and the increase in susceptibility to pyelonephritis in potassium-depleted rats all seem clearly established (20) , such a chain of events to account for the present findings seems improbable. The duration of angiotensin effect was brief. Moreover, angiotensin appears to have insignificant steroidogenic potency in the rat (21) . Finally, increased susceptibility to pyelonephritis with potassium depletion appears to depend on the production of tubular damage, which requires prolonged deprivation of this electrolyte (20, 22) . In addition, the enhancement of susceptibility by norepinephrine could not be explained on the basis of electrolyte change.
A hemodynamic mechanism for altered susceptibility is supported by studies of the effect of angiotensin on renal blood flow. Barer (10) noted that in the anesthesized cat, renal blood flow is reduced by both intravenous and intra-arterial injection of angiotensin and that the time course of flow reduction was usually similar to that of the blood pressure changes. During angiotensin infusion studies in man, other investigators have regularly observed an increased intraglomerular pressure and reduced renal blood flow (23) .
In rats, infusion of angiotensin reduces renal blood flow and increases vascular resistance; indeed, the kidney is the only organ in this species that consistently demonstrates a diminished flow, whereas in the brain, heart, and lungs it may be unchanged or even increased (24) . This was demonstrated clearly in our studies by the direct observation of the blanching of the kidney at the height of blood pressure elevation. A period of engorgement followed this episode of blanching.
It seems clear, therefore, that angiotensin has a profound effect on renal blood flow. Norepinephrine acts similarly on the kidney, but to a lesser extent, as indicated both by our observations that blanching of the kidney was not seen grossly with 10 jug of norepinephrine and by evidence that its effect is more generalized and proportionately greater than that of angiotensin in peripheral areas such as muscle (11, 12) . Decreased renal flow and increased resistance with norepinephrine have been shown by Mehrizi and Hamilton to result in a delayed transit time of blood through the kidney (25) . Angiotensin, with its even more marked hemodynamic effects on the kidney, presumably would produce a similar delay in transit time. This was suggested visually in the present study by the period of engorgement observed after the initial blanching after angiotensin injection. Other possible consequences of the acute hemodynamic changes 'that might play a role are anoxic injury to vascular epithelium that could permit escape of bacteria to interstitial sites and increased hydrostatic forces that might influence bacterial transudation. In any case, these various mechanisms could result in "trapping" of bacteria in the kidney for a long enough period to allow them to begin to propagate and establish infection.
Although no differences in numbers of bacteria per gram of kidney were demonstrated at 1 or 4 hours after inoculation, or long after return of grossly normal appearance of the kidney in the rats receiving the E. coli-angiotensin mixture, the bacteremia then present may have obscured small differences in renal bacterial counts. By 24 hours, when bacteremia had decreased in intensity, a difference was clearly demonstrated. Indeed, the slightly more rapid clearance of bacteria from the blood in the animals with E. coli-angiotensin would favor the concept of renal trapping, as does the demonstration that norepinephrine, which obviously disturbed renal hemodynamics less, had lesser effects on altering renal bacterial levels and susceptibility to infection.
This study has demonstrated that a change in renal blood flow, rather than elevation of blood pressure itself, has enhanced vulnerability of the rat kidney to infection. However, inasmuch as this type of renal vascular change usually is associated with a pressor stimulus, the findings have pertinence to hypertensive states. Moreover, that endogenously available vasoconstrictor materials can result in increased vulnerability to renal infection is an observation that alone has implications in the pathogenesis of hematogenous pyelonephritis.
SUM MARY
An acute episode of hypertension was produced in rats by intravenous injections of angiotensin or norepinephrine. In rats that received E. coli with the vasoconstrictor agent, pyelonephritis was exhibited to a significantly greater extent than in rats challenged with E. coli only. The short duration of the hypertension produced indicates that alterations in renal blood flow may be the important factor in the previously observed vulnerability of hypertensive rats to pyelonephritis.
